US Patent Issued to Bristol-Myers Squibb on May 6 for "Antibody comprising a glutamine-containing light chain C-terminal extension, conjugates thereof, and methods and uses" (California, Washington Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,570, issued on May 6, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Antibody comprising a glutamine-containing light chain C-terminal extension, conjugates thereof, and methods and uses" was invented by Pavel Strop (San Mateo, Calif.), Chetana Rao-Naik (Walnut Creek, Calif.), Xiaodi Deng (San Mateo, Calif.), Paul O. Sheppard (Granite Falls, Wash.), Patrick G. Holder (Piedmont, Calif.) and Sayumi Yamazoe (Mountain View, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An antibody has a glutamine-containing extension at the C-terminus of a light chain thereof, making it suitable for conjugation via transglutaminase-mediated transam...